A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

Bayer's $63 billion purchase in 2018 of seeds and pesticides maker Monsanto was a long-term bet on robust growth in farming ...

Representational Photo Srinagar- Jammu and Kashmir is grappling with a surge in cancer cases, with over 12,000 new cases ...

Cancer cases in Commonwealth countries, including India, are expected to double, said a study published by The Lancet ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

Of the 295 pesticides analysed, 22 were found to be consistently associated with increased prostate cancer incidence across ...

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

Increasing numbers of older US men with prostate cancer are undergoing treatments that carry risks of side effects that can ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

A contemporary study finds that overtreatment of prostate cancer is still occurring among older men with limited life expectancy.

Scientists uncover functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive prostate ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...